Targeting the NRG1/HER3 pathway in tumor cells and cancer-associated fibroblasts with an anti-neuregulin 1 antibody inhibits tumor growth in pre-clinical models of pancreatic cancer - Université de Montpellier Accéder directement au contenu
Article Dans Une Revue Cancer Letters Année : 2018

Targeting the NRG1/HER3 pathway in tumor cells and cancer-associated fibroblasts with an anti-neuregulin 1 antibody inhibits tumor growth in pre-clinical models of pancreatic cancer

Fichier principal
Vignette du fichier
Ogier et al-Cancer Letters-2018.pdf (1.43 Mo) Télécharger le fichier
Origine : Fichiers produits par l'(les) auteur(s)
Loading...

Dates et versions

hal-02350723 , version 1 (06-11-2019)

Identifiants

Citer

Charline Ogier, Pierre-Emmanuel Colombo, Corinne Bousquet, Lucile Canterel-Thouennon, Pierre Sicard, et al.. Targeting the NRG1/HER3 pathway in tumor cells and cancer-associated fibroblasts with an anti-neuregulin 1 antibody inhibits tumor growth in pre-clinical models of pancreatic cancer. Cancer Letters, 2018, 432, pp.227-236. ⟨10.1016/j.canlet.2018.06.023⟩. ⟨hal-02350723⟩
196 Consultations
480 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More